0 items USD 0.00Search
Your search for "ark patent intelligence varenicline patent extension data exclusivity expiry snapshot 51" gave back 114 results.
Pharmaceutical Lifecycle Management Strategies in 2017 Summary GBI Research’s latest report, "Pharmaceutical Lifecycle Management Strategies in...
CBR Pharma Insights
April 2017
Price: USD 2,995.00
Life Cycle Management Strategies Optimizing revenues and defending generic competition discusses various stages of product lifecycle management (LCM...
Catalog:
CBR Pharma Insights
July 2015
Price: USD 2,995.00
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
Catalog:
La Merie Publishing
March 2014
Price: USD 1,514.00
Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence...
Grace Market Data
November 2023
Price: USD 2,600.00
North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the...
Grace Market Data
November 2023
Price: USD 2,600.00
Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by...
Grace Market Data
November 2023
Price: USD 2,600.00
EGF-R Antibodies –Biosimilars and Biosuperiors The present Competitive Intelligence Report about EGF-R Antibodies –Biosimilars and Biosuperiors...
Catalog:
La Merie Publishing
March 2014
Price: USD 344.00
TNF Antibodies –Biosimilars and Biosuperiors The present Competitive Intelligence Report about TNF Antibodies –Biosimilars and Biosuperiors provides...
Catalog:
La Merie Publishing
March 2014
Price: USD 551.00
Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of...
Grace Market Data
November 2023
Price: USD 3,200.00
This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of October 2016. Featured presentations of...
Catalog:
La Merie Publishing
November 2016
Price: USD 225.00
Anti-Her2 Antibody-Drug Conjugates in: September 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf report contains information...
Catalog:
La Merie Publishing
October 2016
Price: USD 225.00
CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains...
Catalog:
La Merie Publishing
October 2016
Price: USD 225.00
CD123-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for Bispecific Antibodies This pdf report contains information...
Catalog:
La Merie Publishing
October 2016
Price: USD 225.00
Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big...
Catalog:
IQ4I
May 2021
Price: USD 7,200.00
The report “Antibody Technologies and Attrition Rates – an industry analysis 2013” is based on the identification of the antibody generation...
Catalog:
La Merie Publishing
March 2013
Price: USD 2,960.00
